Psychiatry Insider is the M&A intelligence platform for psychiatry and behavioral health. We publish valuation insight, market data, and plain-English deal guidance for the people navigating a sale, acquisition, or recapitalization — practice owners, operators, and investors. We sit where two worlds meet: the clinical credibility of psychiatry and the financial rigor of investment banking. We’re editorial first. We earn trust through knowledge, not pitches — and when a reader is ready to act, we connect them with the advisory team at Olympic M&A.
To become the most trusted source of M&A intelligence in psychiatry and behavioral health — the publication a practice owner reads for two years before they ever pick up the phone.
To give psychiatry practice owners the same caliber of market intelligence, valuation insight, and deal guidance that institutional buyers have always had — so every founder negotiates from a position of knowledge, not vulnerability.
Once a month, one clear-eyed read on psychiatry’s deal market: where valuation multiples are moving, who’s buying, and what it means for practice owners. Data with honest caveats — no hype, no spam. Just the intelligence you’d want before you ever pick up the phone.
Start with the knowledge. When you’re ready for a confidential conversation, the specialist advisors at Olympic M&A handle psychiatry and behavioral health deals exclusively.
